Beta Thalassemia. Cooley anaemiaSevere beta thalassaemia Thalassaemia:•intermedia
Conditions
Interventions
Intervention 1: Control group: these people are selected from specific diseases Aboureihan center in Bandar Abbas. We give them the tools to complete their And 1.5 months later, without any intervent
Control group: these people are selected from specific diseases Aboureihan center in Bandar Abbas. We give them the tools to complete their And 1.5 months later, without any intervention so that only
Intervention Group: Sampling available. these people are selected from specific diseases Aboureihan center in Bandar Abbas. After obtaining the written consent of the subjects in the experimental gro
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
81 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria included: • A partnership a family member with patient • have at least read and write to the patient and Active member of the family • Having Medical records in center • Lack of specific mental health problem • Ability to participate in the program Exclusion criteria included: • Unwillingness of the patient and an active member of family to participate in the study. • Unwillingness of the patient and an active member of family to participate in Problem solving and training sessions.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General self- efficacy. Timepoint: Before the intervention, after the intervention. Method of measurement: Schwarzer General Self-Efficacy Scale( GSE-10).;Disease-related self-efficacy. Timepoint: Before the intervention, after the intervention. Method of measurement: Sickle Cell Self-Efficacy Scale(SCSES). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeili Borimnejad
ran University of Medical Sciences
Outcome results
None listed